Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
28 Apr 2022
Historique:
received: 08 09 2021
accepted: 06 04 2022
revised: 27 03 2022
entrez: 28 4 2022
pubmed: 29 4 2022
medline: 29 4 2022
Statut: aheadofprint

Résumé

Allelic variation to the APOE gene confers the greatest genetic risk for sporadic Alzheimer's disease (AD). Independent of genotype, low abundance of apolipoprotein E (apoE), is characteristic of AD CSF, and predicts cognitive decline. The mechanisms underlying the genotype and apoE level risks are uncertain. Recent fluid and imaging biomarker studies have revealed an unexpected link between apoE and brain iron, which also forecasts disease progression, possibly through ferroptosis, an iron-dependent regulated cell death pathway. Here, we report that apoE is a potent inhibitor of ferroptosis (EC

Identifiants

pubmed: 35484240
doi: 10.1038/s41380-022-01568-w
pii: 10.1038/s41380-022-01568-w
pmc: PMC9757994
mid: NIHMS1851727
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIA NIH HHS
ID : R01 AG017917
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG054057
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG054057
Pays : United States
Organisme : Alzheimer's Association
ID : AARFD-16-442821
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Mol Cell Proteomics. 2012 Nov;11(11):1389-403
pubmed: 22918225
J Neuropathol Exp Neurol. 2010 Feb;69(2):155-67
pubmed: 20084018
Neurobiol Dis. 2000 Feb;7(1):23-37
pubmed: 10671320
Br J Nutr. 2013 Nov;110(10):1751-9
pubmed: 23631810
Am J Clin Nutr. 2007 Apr;85(4):1103-11
pubmed: 17413112
Br J Pharmacol. 2020 Feb;177(3):656-667
pubmed: 31655003
Alzheimers Dement. 2018 Feb;14(2):230-242
pubmed: 28945989
Physiol Behav. 2011 Nov 30;105(1):124-8
pubmed: 21536059
J Neurol Neurosurg Psychiatry. 2018 May;89(5):456-460
pubmed: 28939683
Neurotherapeutics. 2018 Oct;15(4):1055-1062
pubmed: 30112699
Free Radic Biol Med. 1999 Sep;27(5-6):544-53
pubmed: 10490274
Dev Cell. 2020 Aug 24;54(4):447-454.e4
pubmed: 32652074
Genes Dev. 2004 Dec 1;18(23):2893-904
pubmed: 15545625
Biol Psychiatry. 2015 Nov 15;78(10):702-10
pubmed: 26003861
Cell. 2018 Jan 25;172(3):409-422.e21
pubmed: 29290465
Sci Rep. 2016 Oct 17;6:35514
pubmed: 27748454
J Alzheimers Dis. 2016;51(3):915-27
pubmed: 26923027
Neurobiol Dis. 2008 Apr;30(1):107-20
pubmed: 18325775
Radiology. 2020 Sep;296(3):619-626
pubmed: 32602825
Am J Clin Nutr. 2008 Feb;87(2):449-54
pubmed: 18258638
Neuroimage. 2020 Jul 15;215:116808
pubmed: 32289451
J Neurosci. 2008 Nov 5;28(45):11445-53
pubmed: 18987181
J Nerv Ment Dis. 1953 Aug;118(2):97-130
pubmed: 13109530
Signal Transduct Target Ther. 2021 Feb 3;6(1):49
pubmed: 33536413
Cell Res. 2016 Sep;26(9):1021-32
pubmed: 27514700
Prog Neurobiol. 2021 Mar;198:101904
pubmed: 32882319
Free Radic Biol Med. 2010 Jun 15;48(12):1570-6
pubmed: 20171275
J Mol Neurosci. 2016 Nov;60(3):325-335
pubmed: 27647307
Brain. 2017 Aug 1;140(8):2112-2119
pubmed: 28899019
J Neurochem. 2016 Oct;139 Suppl 1:179-197
pubmed: 26545340
Nature. 2014 May 1;509(7498):105-9
pubmed: 24695223
FEBS Lett. 2019 Jun;593(11):1144-1153
pubmed: 31058310
JAMA Neurol. 2017 Jan 1;74(1):122-125
pubmed: 27893873
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3374-9
pubmed: 18296641
Curr Alzheimer Res. 2012 Jul;9(6):646-63
pubmed: 22471867
Neurology. 2007 Nov 13;69(20):1921-30
pubmed: 17998483
Neurology. 2005 Nov 8;65(9):1409-14
pubmed: 16275829
Neurobiol Dis. 2015 Sep;81:38-48
pubmed: 26117305
J Alzheimers Dis. 2010;21(4):1165-77
pubmed: 21504121
Nat Cell Biol. 2014 Dec;16(12):1180-91
pubmed: 25402683
Sci Adv. 2021 Jun 9;7(24):
pubmed: 34108207
Neurobiol Aging. 2011 Dec;32(12):2317.e13-22
pubmed: 20570406
Br J Pharmacol. 2019 Sep;176(18):3622-3635
pubmed: 30632143
Neuroreport. 1994 Dec 20;5(18):2534-6
pubmed: 7696597
J Alzheimers Dis. 2020;74(3):975-990
pubmed: 32116250
JAMA. 2010 Nov 3;304(17):1903-11
pubmed: 21045096
J Biol Chem. 2002 Dec 27;277(52):50380-5
pubmed: 12393895
Sci Transl Med. 2021 Mar 3;13(583):
pubmed: 33658354
Elife. 2014 May 20;3:e02523
pubmed: 24844246
Aging (Albany NY). 2017 Mar 23;9(3):964-985
pubmed: 28333036
Arch Pathol Lab Med. 2001 Apr;125(4):510-2
pubmed: 11260625
Nat Chem Biol. 2017 Jan;13(1):81-90
pubmed: 27842066
AJNR Am J Neuroradiol. 2017 Jun;38(6):1130-1137
pubmed: 28341718
Neurobiol Dis. 2019 Apr;124:335-339
pubmed: 30557658
Mol Neurodegener. 2007 Jan 22;2:2
pubmed: 17241462
Alzheimers Dement. 2021 Jul;17(7):1244-1256
pubmed: 33491917
Acta Neuropathol. 2014 May;127(5):621-32
pubmed: 24385135
Brain Res. 1991 Feb 8;541(1):163-6
pubmed: 2029618
Mol Cell. 2019 Jan 17;73(2):354-363.e3
pubmed: 30581146
J Neurochem. 1960 Jun;5:307-10
pubmed: 14399117
J Inherit Metab Dis. 2015 Jan;38(1):123-36
pubmed: 25300979
Nat Rev Cancer. 2020 Feb;20(2):74-88
pubmed: 31686003
Protein Expr Purif. 2011 Oct;79(2):251-7
pubmed: 21712092
Neurobiol Aging. 2006 Aug;27(8):1094-9
pubmed: 15993986
Hum Mol Genet. 2012 Oct 15;21(20):4558-71
pubmed: 22821396
Alzheimers Dement (Amst). 2020 Feb 07;12(1):e12002
pubmed: 32211498
Neurology. 2011 Mar 22;76(12):1091-8
pubmed: 21422459
Mol Psychiatry. 2020 Nov;25(11):2932-2941
pubmed: 30778133
Biochemistry. 2000 Sep 26;39(38):11657-66
pubmed: 10995233
Semin Cancer Biol. 2020 Nov;66:89-100
pubmed: 30880243
Cell. 2012 May 25;149(5):1060-72
pubmed: 22632970
Cell Chem Biol. 2019 Mar 21;26(3):420-432.e9
pubmed: 30686757
Nat Commun. 2015 May 19;6:6760
pubmed: 25988319
Neurotherapeutics. 2021 Oct;18(4):2682-2691
pubmed: 34498224

Auteurs

Abdel Ali Belaidi (AA)

Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3052, Australia.

Shashank Masaldan (S)

Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3052, Australia.

Adam Southon (A)

Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3052, Australia.

Pawel Kalinowski (P)

Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3052, Australia.

Karla Acevedo (K)

Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3052, Australia.

Ambili T Appukuttan (AT)

Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3052, Australia.

Stuart Portbury (S)

Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3052, Australia.

Peng Lei (P)

Department of Neurology and State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.

Puja Agarwal (P)

Rush Alzheimer Disease Center, Rush University Medical Center, Chicago, United States.

Sue E Leurgans (SE)

Rush Alzheimer Disease Center, Rush University Medical Center, Chicago, United States.

Julie Schneider (J)

Rush Alzheimer Disease Center, Rush University Medical Center, Chicago, United States.

Marcus Conrad (M)

Helmholtz Zentrum München, Institute of Metabolism and Cell Death, 85764, Neuherberg, Germany.
Pirogov Russian National Research Medical University, Laboratory of Experimental Oncology, Moscow, 117997, Russia.

Ashley I Bush (AI)

Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3052, Australia. ashley.bush@florey.edu.au.

Scott Ayton (S)

Melbourne Dementia Research Centre, Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3052, Australia. scott.ayton@florey.edu.au.

Classifications MeSH